Minerva Neurosciences, Inc.
NERVNASDAQHealthcare● Active
$4.63
$-0.33(-6.65%)
Market Cap$32377442
P/E Ratio—
52W High$12.46
52W Low$1.566
Minerva Neurosciences, Inc. (NERV) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NERV · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.01B | $0.01B | $0.01B | $0.03B |
| G&A Expenses | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Total Operating Expenses | $0.02B | $0.02B | $0.02B | $0.03B | $0.05B |
| Operating Income | ($0.02B) | ($0.02B) | ($0.02B) | ($0.03B) | ($0.05B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.01B | $0.01B | $0.01B |
| Income Before Tax | ($0.29B) | $0.00B | ($0.03B) | ($0.03B) | ($0.05B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Net Income | ($0.29B) | $0.00B | ($0.03B) | ($0.03B) | ($0.05B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-34.67 | $0.19 | $-4.61 | $-6.01 | $-9.35 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| EBITDA | ($0.29B) | $0.01B | ($0.02B) | ($0.02B) | ($0.05B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Minerva Neurosciences, Inc. data
About Minerva Neurosciences, Inc. (NERV) Income Statement
Minerva Neurosciences, Inc. (NERV) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NERV reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.29B) — a net profit margin of —.
Frequently asked questions
NERV · 4 questionsMinerva Neurosciences, Inc. (NERV) reported revenue of $0.00B for 2025, down —% year-over-year.
NERV revenueNERV salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09